Veri

Helsinki, Finland Founded: 2019 • Age: 7 yrs Acquired By Oura
Continuous glucose monitoring system is provided for blood sugar levels.

About Veri

Veri is a company based in Helsinki (Finland) founded in 2019 by Verneri Jaamuru was acquired by Oura in September 2024. It operates as a HealthTech and Subscription Services. Veri has raised $4 million across 1 funding round from investors including Oura, Accel and PROfounders Capital Partners. Veri offers products and services including Personalized Metabolic Health Program and Continuous Glucose Monitoring (CGM). Veri operates in a competitive market with competitors including Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.

  • Headquarter Helsinki, Finland
  • Founders Verneri Jaamuru
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website veri.co
  • Social LinkedIn X Facebook Instagram YouTube
  • Acquired by Oura (Sep 2024)
  • Legal Name Human Engineering Health Oy
Key Metrics
  • Total Equity Funding
    $4M (USD)

    in 1 rounds

  • Latest Funding Round
    $4M (USD), Seed

    Jun 2021

  • Investors
    Oura

    & 5 more

  • Acquired by
    Oura

    (Sep 2024)

Products & Services of Veri

Veri offers a comprehensive portfolio of products and services, including Personalized Metabolic Health Program and Continuous Glucose Monitoring (CGM).

Personalized Metabolic Health Program
Health Technology

A program to stabilize blood sugar levels effectively.

Continuous Glucose Monitoring (CGM)
Health Technology

Real-time glucose monitoring without finger pricking used.

Apps and channels of Veri

its YouTube channel Veri has 551 subscribers.

Veri
YouTube 551 subscribers
Open channel

Funding Insights of Veri

Veri has successfully raised a total of $4M through 1 strategic funding round. The most recent funding activity was a Seed round of $4 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $4M
  • Total Rounds 1
  • Last Round Seed β€” $4M
  • First Round $4M

    (Jun 2021)

  • Investors Count 5

All 1 funding rounds of Veri with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2021$4MSeed–PROfounders Capital Partners
Valuation history

6 investors in total: 4 institutional and 2 angel.

Investors in Veri

Veri has secured backing from 6 investors, including venture fund and angel investors. Prominent investors backing the company include Oura, Accel and PROfounders Capital Partners.

All
Venture Fund
Angel
InvestorDescriptionFounded YearDomainLocation
VC firm investing in Europe
–profounderscapital.comLondon, United Kingdom
Early-stage venture capital is invested in European startups across sectors.
–lifelineventures.comHelsinki, Finland
Accel is recognized as a leading venture capital firm.
1983accel.comPalo Alto, United States

Johannes Schildt

CEO of Kry, active angel investor in Indian startups
–unknown_b3b34d96ddd04b998-

Kristian Ranta

Co-founder of Meru Health, active angel investor in health tech
–unknown_223bc8e845674c128-
Health-tracking smart rings and biosensors are developed for biometric monitoring.
2013ouraring.comOulu, Finland
Premium access

Investor details for Veri

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Veri

4 people are tracked at Veri (4 in leadership).

NameRoleGroup
Verneri Jaamuru
Co-FounderLeadership
Anttoni Aniebonam
CEO & Co-FounderLeadership
Adam Robinson
Head of GrowthLeadership
Frans Lehmusvaara
CTO & Co-FounderLeadership
Premium access

Complete people profiles for Veri

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Veri

3 dated milestones of Veri across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Veri is founded.
  2. Funding First funding round of $4.0M.
  3. Exit Acquired by Oura.

Competitors of Veri

Veri operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, One Drop, mySugr and Senseonics, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
dexcom.com1999San Diego, United States$52.5M9,600
Wearable glucose monitoring patches are provided for real-time data tracking.
livongo.com2014San Francisco, United States$245.2M3,263
Provider of smart devices for diabetes management for patients and doctors
onedrop.today2015New York, United States$107.87M166
Provider of workforce healthcare solutions
mysugr.com2012Vienna, Austria$4.8M–
Gamified apps for diabetes management and therapy are provided.
senseonics.com1996Germantown, United States$175.46M132
Implantable continuous glucose monitoring systems are provided for diabetes management.
janacare.com2011Newton, United States$26.59M–
Mobile-based diagnostics for diabetes prevention and management are provided.
telcare.com2008Bethesda, United States$66.69M21
Diabetes is managed via cellular technology and social networking.
caura.com2016London, United Kingdom$4.2M11
Auto insurance and vehicle services are provided via mobile app.
levels.com2019United States$67M35
Wearable devices for metabolic health insights are provided.
companionmedical.com2013San Diego, United States$24.09M–
Smart insulin pens with Bluetooth smartphone connectivity are developed.
Premium access

Detailed competitors of Veri

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Veri

The website of Veri (veri.co) receives about 76.9K visits a month.

  • Monthly visits
    76.9K

    ▼ 7.8% vs previous month

Similar websites

Websites whose visitors overlap most with Veri. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
type1better.com
type1better.com
100%
–#1,242,905–
heartcare.sydney
heartcare.sydney
97%
–#1,206,355–
diabetes.co.uk
diabetes.co.uk
88%
–#118,082–
pitstopdiabetes.co.uk
pitstopdiabetes.co.uk
86%
–#1,010,503–
soc-bdr.org
soc-bdr.org
86%
–#3,729,262–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 27 similar websites and full traffic analytics for Veri

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 27 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Latest news on Veri

Premium access

Complete news archive for Veri

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Veri

10 companies that operate in the same segment as Veri (Diabetes), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of devices for continuous glucose monitoring and manual insulin delivery
2008San Diego, California, United StatesUSD 100.73 MUSD 1.02 B2,650
Wearable glucose monitoring patches are provided for real-time data tracking.
1999San Diego, California, United StatesUSD 52.5 MUSD 4.66 B10,300
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Small molecule drugs for various therapeutic areas are developed.
1995United StatesUSD 165 MUSD 49.8 M103
Implantable continuous glucose monitoring systems are provided for diabetes management.
1996Germantown, United StatesUSD 175.46 MUSD 22.47 M117
Developer of a closed-loop automated insulin delivery system
2014Milpitas, California, United StatesUSD 214.51 M–133
Provider of workforce healthcare solutions
2015New York, New York, United StatesUSD 107.87 M–166
Diabetes care and reversal programs are provided to patients.
2021Bengaluru, Karnataka, IndiaUSD 26.7 MUSD 5.07 M677
Provider of smart devices for diabetes management for patients and doctors
2014San Francisco, California, United StatesUSD 245.2 M––
Genetically engineered cell therapies are developed for multiple disorders.
2018Seattle, Washington, United StatesUSD 821 M–194
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Veri

Veri was founded in 2019 and raised its 1st funding round 2 years after it was founded.

Veri is headquartered in Helsinki, Finland.

Veri is a funded company, having raised a total of $4M across 1 funding round to date. The company's 1st funding round was a Seed of $4M, raised on Jun 2021.

A personalized metabolic health program is provided by Veri to help users stabilize blood sugar levels and achieve health goals. Guidance on suitable foods and habits is delivered through cutting-edge continuous glucose monitoring and AI-driven meal logging. Insights and daily recommendations are offered to transform health outcomes in the digital health sector, focusing on metabolic health solutions.

Veri's top competitors include Dexcom, Senseonics and One Drop.

Veri offers Personalized Metabolic Health Program and Continuous Glucose Monitoring (CGM).

Veri has 6 investors. Key investors include Oura, Accel, PROfounders Capital Partners, Lifeline Ventures, and Johannes Schildt.

Veri operates through Human Engineering Health Oy.

Yes. Veri was acquired by Oura in September 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available